| scholarly article | Q13442814 |
| P50 | author | Renxi Wang | Q59677235 |
| Yinxiang Wei | Q85371355 | ||
| Gencheng Han | Q88750898 | ||
| Guojiang Chen | Q120564554 | ||
| Beifen Shen | Q120564569 | ||
| Chunmei Hou | Q120564954 | ||
| P2093 | author name string | Yan Li | |
| Xiaoling Liu | |||
| He Xiao | |||
| Xiaoqian Wang | |||
| P2860 | cites work | TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease | Q22254041 |
| BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma | Q24646563 | ||
| Antiviral CD4+ memory T cells are IL-15 dependent | Q24676283 | ||
| The role of the BAFF/APRIL system on T cell function | Q28259870 | ||
| Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus | Q33928629 | ||
| BAFF promotes Th17 cells and aggravates experimental autoimmune encephalomyelitis | Q34012753 | ||
| BAFF and innate immunity: new therapeutic targets for systemic lupus erythematosus | Q34245983 | ||
| TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1. | Q34579440 | ||
| Validation of a novel biomarker for acute axonal injury in experimental autoimmune encephalomyelitis. | Q34809963 | ||
| IL-15 is a growth factor and an activator of CD8 memory T cells | Q35049746 | ||
| Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice | Q35110335 | ||
| Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations | Q36375661 | ||
| An APRIL to remember: novel TNF ligands as therapeutic targets | Q36394955 | ||
| Taming lupus-a new understanding of pathogenesis is leading to clinical advances | Q36712941 | ||
| Cracking the BAFF code. | Q37517172 | ||
| Memory B and memory plasma cells | Q37781393 | ||
| Resolution of psoriasis upon blockade of IL-15 biological activity in a xenograft mouse model | Q40156550 | ||
| Interleukin 15: a key to disrupted intraepithelial lymphocyte homeostasis and lymphomagenesis in celiac disease | Q40638913 | ||
| hsBAFF regulates proliferation and response in cultured CD4(+) T lymphocytes by upregulation of intracellular free Ca(2+) homeostasis | Q43957984 | ||
| Active induction of experimental allergic encephalomyelitis | Q48175463 | ||
| Combination of TACI-IgG and anti-IL-15 treats murine lupus by reducing mature and memory B cells. | Q50850569 | ||
| BAFF suppresses IL-15 expression in B cells. | Q50855805 | ||
| Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis. | Q51027456 | ||
| Endogenous leukemia inhibitory factor production limits autoimmune demyelination and oligodendrocyte loss | Q58425792 | ||
| TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease. impaired B cell maturation in mice lacking BLyS | Q74419758 | ||
| Nonclinical safety, pharmacokinetics, and pharmacodynamics of atacicept | Q81394138 | ||
| Therapeutic effects of TACI-Ig on collagen-induced arthritis by regulating T and B lymphocytes function in DBA/1 mice | Q83230096 | ||
| BAFF induces spleen CD4+ T cell proliferation by down-regulating phosphorylation of FOXO3A and activates cyclin D2 and D3 expression | Q84811169 | ||
| TACI-Ig induces immune balance of Th cells in MLN via BLyS/APRIL-receptors signaling in rats with adjuvant-induced arthritis | Q85090315 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 142-148 | |
| P577 | publication date | 2015-08-03 | |
| P1433 | published in | Central-European Journal of Immunology | Q15764592 |
| P1476 | title | Blockade of B-cell activating factor with TACI-IgG effectively reduced Th1 and Th17 cells but not memory T cells in experimental allergic encephalomyelitis mice | |
| P478 | volume | 40 |
| Q38961202 | B Cell-Activating Factor (BAFF)-Targeted B Cell Therapies in Inflammatory Bowel Diseases. |
| Q52577393 | Human central nervous system astrocytes support survival and activation of B cells: implications for MS pathogenesis. |
| Q41594953 | Salutary effects of glibenclamide during the chronic phase of murine experimental autoimmune encephalomyelitis |
| Q92302527 | The role of B cells in multiple sclerosis: Current and future therapies |
Search more.